'High value' drug suspect shot dead in Quezon | Inquirer News

‘High value’ drug suspect shot dead in Quezon

By: - Correspondent / @dtmallarijrINQ
/ 04:23 PM March 23, 2017

INQUIRER.NET FILE PHOTO

INQUIRER.NET FILE PHOTO

LUCENA CITY – A suspected drug pusher listed as a “high value target drug personality” was shot dead by motorcycle-riding gunmen in Infanta town in Quezon province on Wednesday, police said Thursday.

Chief Insp. Mark Amat, Infanta police chief, said the victim, Joel Fernandez, alias “Bistong”, 44, was standing along Malvar street in the town proper when he was shot several times by a still unidentified gunman, who used a .45-pistol around 8:30 p.m.

Article continues after this advertisement

After the shooting, the killer escaped aboard a motorcycle with his accomplice. Amat, citing witnesses’ accounts, described the killers as both wearing bonnets.

FEATURED STORIES

Fernandez died while being taken to the Claro M. Recto hospital.

Amat said investigators have been pursuing different angles on the possible motives behind the killing, including personal enemies and illegal drug trafficking.

Article continues after this advertisement

“He was a notorious drug pusher in the town. He was also a known drug user,” Amat said in a phone interview.  SFM/rga

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Bistong, Crime, Drug trafficking, Infanta municipal police, Mark Amat, Murder, quezon, shabu, Shooting

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.